Innervation patterns may limit response to endovascular renal denervation

Journal of the American College of Cardiology

Volumn 64, Issue 11, 2014, Pages 1079-1087

  Tzafriri, Abraham R ^a   Mahfoud, Felix ^b   Keating, John H ^a   Markham, Peter M ^a   Spognardi, Anna ^a   Wong, Gee ^a   Fuimaono, Kristine ^c   Böhm, Michael ^b   Edelman, Elazer R ^d,e  

^a CBSET Inc   (United States)

^b SAARLAND UNIVERSITY   (Germany)

^c Biosense Webster Belgium   (Belgium)

^d Massachusetts Institute of Technology Cambridge   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Aortic tortuosity; Renal denervation; Superior ostium

Indexed keywords

NORADRENALIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CATHETER ABLATION; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; ENDOVASCULAR SURGERY; GANGLION; KIDNEY DENERVATION; KIDNEY INJURY; KIDNEY NERVE; NONHUMAN; OUTCOME ASSESSMENT; PATHOLOGICAL ANATOMY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; RENAL ARTERY; SWINE; TREATMENT RESPONSE; ANIMAL; INNERVATION; KIDNEY ARTERY; MALE; PIG; SURGERY; SYMPATHECTOMY; TREATMENT OUTCOME;

ANIMALS; CATHETER ABLATION; ENDOVASCULAR PROCEDURES; MALE; RENAL ARTERY; SWINE; SYMPATHECTOMY; TREATMENT OUTCOME;

EID: 84921449053     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2014.07.937     Document Type: Article

References (23)

1. Mahfoud F, Ukena C, Schmieder RE, et al. Ambulatory blood pressure changes after renal sympathetic denervation in patients with resistant hypertension. Circulation 2013;128:132-40.
2. Kaiser L, Beister T, Wiese A, et al. Results of the ALSTER BP real-world registry on renal denervation employing the Symplicity system. Euro-Intervention 2014;10:157-65.
3. Persu A, Azizi M, Burnier M, Staessen JA. Residual effect of renal denervation in patients with truly resistant hypertension. Hypertension 2014; 62:450-2.
4. Ott C, Mahfoud F, Schmid A, et al. Renal denervation in moderate treatment-resistant hypertension. J Am Coll Cardiol 2013;62:1880-6.
5. Esler MD, Krum H, Schlaich M, Schmieder RE, Bohm M, Sobotka PA. Renal sympathetic denervation for treatment of drug-resistant hypertension: one-year results from the Symplicity HTN-2 randomized, controlled trial. Circulation 2012;126: 2976-82.
6. Krum H, Schlaich MP, Bohm M, et al. Percutaneous renal denervation in patients with treatment-resistant hypertension: final 3-year report of the Symplicity HTN-1 study. Lancet 2014;383:622-9.
7. Bhatt DL, Kandzari DE, O'Neill WW, et al. A controlled trial of renal denervation for resistant hypertension. N Engl J Med 2014;370:1393-401.
8. Mahfoud F, Bhatt DL. Catheter-based renal denervation: the black box procedure. J Am Coll Cardiol Intv 2013;6:1092-4.
9. Bertog SC, Blessing E, Vaskelyte L, Hofmann I, Id D, Sievert H. Renal denervation: tips and tricks to perform a technically successful procedure. EuroIntervention 2013;9 Suppl R:R83-8.
10. Tsioufis C, Mahfoud F, Mancia G, et al. What the interventionalist should know about renal denervation in hypertensive patients: a position paper by the ESH WG on the interventional treatment of hypertension. EuroIntervention 2014;9:1027-35.
11. Atherton DS, Deep NL, Mendelsohn FO. Microanatomy of the renal sympathetic nervous system: a human postmortem histologic study. Clin Anat 2011;25:628-33.
12. Tellez A, Rousselle S, Palmieri T, et al. Renal artery nerve distribution and density in the porcine model: biologic implications for the development of radiofrequency ablation therapies. Transl Res 2013;162:381-9.
13. Sakakura K, Ladich E, Cheng Q, et al. Anatomical distribution of human renal sympathetic nerves: pathologic study. J Am Coll Cardiol 2014;63:A2151.
14. NRC (National Research Council). Guide for the Care and Use of Laboratory Animals. Washington, DC: National Academy Press, 1996.
15. Ji C, Walton J, Su Y, Tella M. Simultaneous determination of plasma epinephrine and norepinephrine using an integrated strategy of a fully automated protein precipitation technique, reductive ethylation labeling and UPLC-MS/MS. Anal Chim Acta 2010;670:84-91.
16. Sakakura K, Ladich E, Edelman ER, et al. Methodological standardization for the preclinical evaluation of renal sympathetic denervation. J Am Coll Cardiol Intv http://dx.doi.org/10.1016/j.jcin. 2014.04.024.
17. Esler M. Renal denervation for hypertension: observations and predictions of a founder. Eur Heart J 2014;35:1178-85.
18. Hering D, Lambert EA, Marusic P, et al. Renal nerve ablation reduces augmentation index in patients with resistant hypertension. J Hypertens 2013;31:1893-900.
19. Mahfoud F, Luscher TF, Andersson B, et al. Expert consensus document from the European Society of Cardiology on catheter-based renal denervation. Eur Heart J 2013;34:2149-57.
20. Hutchinson BD, Keane D, Dodd JD. Renal sympathetic denervation: MDCT evaluation of the renal arteries. AJR Am J Roentgenol 2013;201: W342-6.
21. Shirali AS, Bischoff MS, Lin HM, et al. Predicting the risk for acute type B aortic dissection in hypertensive patients using anatomic variables. J Am Coll Cardiol Img 2013;6:349-57.
22. Worthley SG, Tsioufis CP, Worthley MI, et al. Safety and efficacy of a multi-electrode renal sympathetic denervation system in resistant hypertension: the EnligHTN I trial. Eur Heart J 2013; 34:2132-40.
23. Ukena C, Cremers B, Ewen S, Bohm M, Mahfoud F. Response and non-response to renal denervation: who is the ideal candidate? Euro-Intervention 2013;9 Suppl R:R54-7.